Advanced Registry Search Results

Search Criteria
  1. Client or organization number: 1197
Start over
Modify criteria
Refine By
Document Type Registrations Status Activity Type Subject Matter of the Lobbying Activity Ministries/Provincial Entities

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Advanced Registry Search Results

Results: 1-16 of 16
  1. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover, President and CEO
    Registration: 16 of 16 (2024-12-03 to present)
    Posted: 2024-12-13
    Subject matter details: 1
    Ministries/Provincial entities: 1
    Gifts or Benefits Provided: No
    Government funding: Yes
    Employees who lobby: 5
  2. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover, President and CEO
    Registration: 15 of 16 (2023-12-12 to 2024-12-03)
    Posted: 2023-12-13
    Subject matter details: 1
    Ministries/Provincial entities: 1
    Gifts or Benefits Provided: No
    Government funding: Yes
    Employees who lobby: 5
  3. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover, President and CEO
    Registration: 14 of 16 (2023-01-31 to 2023-12-01)
    Posted: 2023-05-17
    Subject matter details: 1
    Ministries/Provincial entities: 1
    Gifts or Benefits Provided: No
    Government funding: Yes
    Employees who lobby: 5
  4. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover, President and CEO
    Registration: 13 of 16 (2022-11-24 to 2023-01-31)
    Posted: 2022-12-09
    Subject matter details: 1
    Ministries/Provincial entities: 1
    Gifts or Benefits Provided: No
    Government funding: Yes
    Employees who lobby: 4
  5. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover, President and CEO
    Registration: 12 of 16 (2022-08-01 to 2022-11-24)
    Posted: 2022-09-07
    Subject matter details: 1
    Ministries/Provincial entities: 1
    Gifts or Benefits Provided: No
    Government funding: Yes
    Employees who lobby: 5
  6. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover, President and CEO
    Registration: 11 of 16 (2022-06-14 to 2022-08-01)
    Posted: 2022-06-15
    Subject matter details: 1
    Ministries/Provincial entities: 1
    Gifts or Benefits Provided: No
    Government funding: Yes
    Employees who lobby: 6
  7. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover, President and CEO
    Registration: 10 of 16 (2021-12-01 to 2022-06-14)
    Posted: 2021-12-13
    Subject matter details: 1
    Ministries/Provincial entities: 1
    Gifts or Benefits Provided: No
    Government funding: Yes
    Employees who lobby: 6
  8. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover, President and CEO
    Registration: 9 of 16 (2021-04-14 to 2021-12-01)
    Posted: 2021-05-03
    Subject matter details: 1
    Ministries/Provincial entities: 1
    Gifts or Benefits Provided: No
    Government funding: Yes
    Employees who lobby: 5
  9. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover
    Registration: 8 of 16 (2020-03-03 to 2020-05-04)
    Posted: 2020-03-04
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: Yes
    Employees who lobby: 5
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  10. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover
    Registration: 7 of 16 (2019-08-06 to 2020-02-06)
    Posted: 2019-08-06
    Subject matter details: 2
    Lobbying target types: 3
    Government funding: Yes
    Employees who lobby: 6
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  11. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover
    Registration: 6 of 16 (2019-01-28 to 2019-07-28)
    Posted: 2019-01-28
    Subject matter details: 1
    Lobbying target types: 1
    Government funding: Yes
    Employees who lobby: 6
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  12. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Kelly Grover
    Registration: 5 of 16 (2018-07-18 to 2019-01-18)
    Posted: 2018-07-18
    Subject matter details: 3
    Lobbying target types: 2
    Government funding: Yes
    Employees who lobby: 5
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  13. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Jennifer Nebesky
    Registration: 4 of 16 (2018-01-04 to 2018-07-04)
    Posted: 2018-01-10
    Subject matter details: 3
    Lobbying target types: 2
    Government funding: Yes
    Employees who lobby: 7
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  14. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Norma Beauchamp
    Registration: 3 of 16 (2017-06-05 to 2017-12-05)
    Posted: 2017-06-05
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: Yes
    Employees who lobby: 4
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  15. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Norma Beauchamp
    Registration: 2 of 16 (2016-11-11 to 2017-05-10)
    Posted: 2016-11-14
    Subject matter details: 1
    Lobbying target types: 1
    Government funding: No
    Employees who lobby: 1
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  16. Cystic Fibrosis Canada
    Activity type: Organization
    Senior Officer: Norma Beauchamp
    Registration: 1 of 16 (2016-05-04 to 2016-10-31)
    Posted: 2016-05-12
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 1
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
Date Modified: